New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 20, 2014
08:27 EDTNWBONorthwest Biotherapeutics reaffirms DCVax-Direct clinical trial interim data
Northwest Biotherapeutics announced that it refuted Adam Feuerstein's "latest false headline and attack on the company", reaffirming the company's recent interim data announcements from its Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumors. The company added, "The Company's DCVax-Direct trial is ongoing. Contrary to Feuerstein's sensationalized false headline, the Company has not received a 'rebuke' from any clinical trial site, nor does the Company believe there is any basis for any such 'rebuke.' The company has consistently said that it would release interim data on an ongoing basis during the course of its DCVax-Direct Phase I/II trial. This trial is a single-arm, unblinded, 'open label; trial, meaning that all of the patients in the trial are receiving the DCVax-Direct treatment, and the clinical results in patients are visible to the Company as the trial goes along.
News For NWBO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
06:09 EDTNWBOStocks with implied volatility movement; NWBO ZIOP
Subscribe for More Information
February 25, 2015
10:12 EDTNWBOHigh option volume stocks
High option volume stocks: WBAI HDS ICON NWBO RGR GFI RKT TJX RSG LC
February 19, 2015
12:57 EDTNWBONW Bio Phase III clinical trial of DCVax-L approved to proceed in Canada
Subscribe for More Information
February 17, 2015
10:29 EDTNWBOHigh option volume stocks
High option volume stocks: RDSA JACK WUBA MT JAKK VDSI ECL ENR AVG NWBO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use